Developer docs
API playgroundTry for free, no card

Search company profiles

Rayyan

Full company profile

uuid00072ww

Namestring
Rayyan
Legal namestring
Rayyan Systems, Inc.
Websiteurl
rayyan.ai
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Rayyan Systems, Inc. is a Cambridge, Massachusetts-based software company that builds an AI-powered platform for conducting systematic literature reviews, a workflow common in academic research, health technology assessment, and evidence-based medicine. The product covers the end-to-end review pipeline — reference import and organization, collaborative screening, AI-assisted relevance prediction, deduplication of up to 200,000 references, PICO extraction, structured data extraction, Risk of Bias assessment, and PRISMA flow diagram generation — and is accessible via web, native iOS and Android apps, and a REST API with MCP server support on the Enterprise tier.

The company's technology stack combines classical systematic review tooling with AI capabilities delivered through a module called ResearchPilot, which offers five modes (AI Reviewer, AI Analyzer, Chat with Your Data, Auto Extraction, Help Center Mode) and is gated to Business and Enterprise customers. The platform is built around a freemium-to-enterprise GTM: a permanent free tier with 3 active reviews acquires individual researchers, followed by Essential ($8.33/month quarterly) and Advanced ($13.33/month quarterly) self-serve paid tiers, then Business and Enterprise tiers requiring a 5-seat minimum with custom pricing, purchase-order and bank-transfer billing, SSO/SAML, and dedicated support. Distribution is hybrid, combining self-serve web and mobile acquisition with an enterprise sales motion supplemented by conferences, content marketing, and a YouTube/community ecosystem.

Rayyan claims 1 million+ researchers across 20,000+ institutions in 190+ countries and 3 million+ systematic reviews conducted on the platform, supported by compliance certifications including SOC 2 Type 2, ISO 27001, HIPAA, GDPR, CCPA, and WCAG 2.2 AA. The company is privately held, founded in 2016, and operates with 11–50 employees.

Short descriptiontext

Rayyan is an AI-powered SaaS platform for conducting systematic literature reviews, serving academic researchers, biopharma/HEOR teams, and institutions with screening, deduplication, PICO extraction, and Risk of Bias tools delivered via web, mobile, and API on freemium and tiered subscription plans.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCambridge, United States
HQ citystring
Cambridge
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
systematic review software, literature review platform, evidence synthesis tools, research collaboration software, AI screening tools
Industry2 codes
PRIMARYBPAHALAN
Healthcare Outcomes & Real-World Evidence (RWE) Analytics
SECONDARYHLACAOAJ
Site & Investigator Platforms (Site Payments, Feasibility, Activation)
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
NAICS code2 codes
  • Scientific Research and Development Services5417
  • Research and Development in the Social Sciences and Humanities54172
SIC code1 code
  • Services-Computer Programming, Data Processing, Etc.7370
Product category
Research Management Software
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Subscription Plans
TypeFreemium
Description

Tiered subscription model with Free, Essential, Advanced, Business/Academic, and Enterprise tiers. Free plan provides basic access with limited features. Paid plans unlock premium AI features, increased reviewer limits, and team management capabilities. Annual billing offers up to 40% savings compared to quarterly.

rayyan.ai
2Per-Seat Licensing
TypeSubscription Recurring
Description

Paid plans priced per seat (Essential and Advanced tiers for individuals/small teams). Business and Enterprise plans require minimum 5 licenses with custom pricing. Seats can be reassigned as team composition changes.

rayyan.ai
3Institutional Subscriptions
TypeSubscription Recurring
Description

Custom pricing for Business/Academic and Enterprise tiers targeting research departments and institutions. Accepts Purchase Orders and offers bank transfers for institutional subscriptions. Minimum 5 license requirement for Business plan.

rayyan.ai
4API Access
TypeSubscription Recurring
Description

API access provided as a feature in Enterprise tier, enabling integrations with external systems and workflows

rayyan.ai
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Pricing details5 tiers
1Free forever plan for individual researchers getting started with systematic reviews
ModelFreemiumBilling cadenceMonthly
Notes

$0 forever. Includes: 3 active reviews, 2 free Reviewers, duplicate detection, AI relevance predictions, 15+ workbench facets, standard support, limited mobile app access.

rayyan.ai
2Essential AI-powered tools for PhD students and postdocs
ModelSubscriptionBilling cadenceQuarterly
Notes

$8.33/month billed quarterly ($4.99/seat/month annually). All Free features plus: Generate PRISMA flow diagrams, invite 5 free Reviewers, auto-resolve duplicates, unlimited mobile app access, multi-select & bulk actions, programmable keyboard shortcuts, dark theme.

rayyan.ai
3Advanced AI-powered tools for serious professional researchers
ModelSubscriptionBilling cadenceQuarterly
Notes

$13.33/month billed quarterly ($8.33/seat/month annually). All Essential features plus: Create 9 active reviews, invite 10 free Reviewers, accelerate screening with AI agents, create unlimited samples, extract PICO data with AI, priority support.

rayyan.ai
4Full platform with ResearchPilot™ AI for research departments and institutions
ModelSubscriptionBilling cadenceAnnual
Notes

Custom pricing with 5 license minimum, billed annually. All Advanced features plus: ResearchPilot™ AI, invite 250 free Reviewers, manage teams from one dashboard, manage 50 org-wide reviews, assign workspace roles, priority support.

rayyan.ai
5Unlimited scale with full governance and dedicated support for large institutions
ModelSubscriptionBilling cadenceAnnual
Notes

Custom per seat per month pricing, billed annually. All Business features plus: Boost productivity ResearchPilot™ AI, add unlimited viewers, create unlimited reviews, enable SSO/SAML, integrate with Rayyan's API, control access from management console, dedicated support.

rayyan.ai
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Rayyan is an AI-powered systematic literature review platform delivered as a tiered SaaS subscription. It enables researchers and institutions to import references, collaborate on screening, deduplicate large reference libraries, extract structured study data, and generate PRISMA-compliant reports. The platform supports the full systematic review workflow from import through reporting, including AI-assisted screening, PICO framework extraction, Risk of Bias assessment, mobile offline screening, and an AI module (ResearchPilot™) for search, screening, and extraction.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Up to 90% time savings on systematic review screening tasks
+3 more records
Product overview1 text field

Rayyan is an AI-powered systematic review and literature review platform offered as a unified SaaS product with tiered subscription plans (Free, Essential, Advanced, Business/Academic, Enterprise). The core platform provides import and organization of references, collaborative screening, deduplication, and PRISMA reporting. The product portfolio includes add-on modules: ResearchPilot™ (AI search, screening, and extraction for institutions with 5 AI modes), Risk Of Bias assessment tool, Workbench for workflow management, Mobile App for iOS/Android, Data Extraction for structured data capture, Systematic Auto Resolver for duplicate removal, PICO Framework for study evaluation, API Access for enterprise integration, and Sampling for randomized subset management. The platform is accessible via web interface, mobile apps, and API, with AI features available across tiers.

Product and service3 records
1Rayyan Systematic Review Platform
CategorySystematic Review Software
Description

AI-powered systematic literature review SaaS platform that enables import and organization of references, collaborative screening, AI-assisted deduplication, structured data extraction, PICO framework extraction, Risk of Bias assessment, and auto-generated PRISMA flow diagram reporting. Sold via tiered subscriptions (Free, Essential, Advanced, Business/Academic, Enterprise) for individual researchers, research departments, institutions, and biopharma customers.

2ResearchPilot™
CategoryAI Research Assistant
Description

AI module for institutional customers offering five specialized modes: AI Reviewer (automated screening with reasoning notes), AI Analyzer (criteria-based evaluation with justification), Chat with Your Data (Q&A across the dataset), Auto Extraction (structured data extraction from PDFs), and Help Center Mode (contextual in-product support). Available on Business/Academic and Enterprise subscription tiers.

3Rayyan Mobile App
CategoryMobile Application
Description

Native mobile application for iOS and Android enabling systematic review screening on the go or offline, with swipe gestures to include/exclude studies, double-tap custom actions, auto-scroll, and offline work capability. Distributed through the Apple App Store (ryn.ai/ios) and Google Play (ryn.ai/android).

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Covidence is a widely adopted SaaS platform purpose-built for systematic review screening, data extraction, and PRISMA reporting, serving academic researchers, Cochrane-style evidence syntheses, and guideline developers. It is the most direct competitor to Rayyan's core screening workflow.

TypeDirect peer
Description

DistillerSR is an AI-enabled systematic review platform used by regulatory-grade health technology assessment (HTA) teams, government agencies, and pharma HEOR groups. Competes head-to-head with Rayyan in the enterprise / regulated evidence synthesis segment.

3EPPI-Reviewer
TypeDirect peer
Description

EPPI-Reviewer is an academic systematic review platform developed at UCL for evidence synthesis, including text mining and machine-learning assisted screening. Comparable to Rayyan for academic and Cochrane-adjacent users.

TypeDirect peer
Description

JBI SUMARI is the Joanna Briggs Institute's systematic review software for evidence-based healthcare, supporting JBI/Meta-Analysis-style reviews. Directly comparable in workflow to Rayyan for nursing, allied health, and clinical systematic reviews.

TypeEmerging player
Description

Elicit is an AI research assistant that uses LLMs to search, summarize, and extract data from academic papers. Overlaps with Rayyan's ResearchPilot™ on AI screening and data extraction but competes more broadly with the full literature review workflow.

TypeEmerging player
Description

Nested Knowledge is a SaaS platform for systematic literature reviews and evidence mapping with built-in PRISMA reporting and AI-assisted extraction. Direct overlap with Rayyan in pharma/medical device evidence synthesis.

TypeEmerging player
Description

Consensus is an AI-powered search engine for scientific research that surfaces synthesized answers from peer-reviewed literature. Adjacent competitor to Rayyan for researchers who use it as an alternative starting point to formal systematic reviews.

8Scite
TypeEmerging player
Description

Scite uses AI to classify how scientific papers cite each other and offers Smart Citations for evidence-based research. Overlaps with Rayyan's screening/extraction value prop for academic and policy researchers.

TypeBroad incumbent
Description

Clarivate owns Web of Science, Derwent, and Cortellis, serving academic and life-science research organizations globally. A broad incumbent whose analytics and discovery tools increasingly overlap with Rayyan's workflow, particularly for institutional customers.

10Elsevier (Embase, Scopus)
TypeBroad incumbent
Description

Elsevier operates Scopus, Embase, ScienceDirect, and tools such as Reaxys that support systematic literature searches and evidence synthesis. A broad incumbent that competes indirectly by integrating discovery and review-adjacent workflows for institutional buyers.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration9 records

Each record includes

Title, Type, Description, Source

AI capability10 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature9 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance7 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Rayyan

Research Management Softwarerayyan.ai

Rayyan is an AI-powered SaaS platform for conducting systematic literature reviews, serving academic researchers, biopharma/HEOR teams, and institutions with screening, deduplication, PICO extraction, and Risk of Bias tools delivered via web, mobile, and API on freemium and tiered subscription plans.

What Rayyan does

Rayyan Systems, Inc. is a Cambridge, Massachusetts-based software company that builds an AI-powered platform for conducting systematic literature reviews, a workflow common in academic research, health technology assessment, and evidence-based medicine. The product covers the end-to-end review pipeline — reference import and organization, collaborative screening, AI-assisted relevance prediction, deduplication of up to 200,000 references, PICO extraction, structured data extraction, Risk of Bias assessment, and PRISMA flow diagram generation — and is accessible via web, native iOS and Android apps, and a REST API with MCP server support on the Enterprise tier.

The company's technology stack combines classical systematic review tooling with AI capabilities delivered through a module called ResearchPilot, which offers five modes (AI Reviewer, AI Analyzer, Chat with Your Data, Auto Extraction, Help Center Mode) and is gated to Business and Enterprise customers. The platform is built around a freemium-to-enterprise GTM: a permanent free tier with 3 active reviews acquires individual researchers, followed by Essential ($8.33/month quarterly) and Advanced ($13.33/month quarterly) self-serve paid tiers, then Business and Enterprise tiers requiring a 5-seat minimum with custom pricing, purchase-order and bank-transfer billing, SSO/SAML, and dedicated support. Distribution is hybrid, combining self-serve web and mobile acquisition with an enterprise sales motion supplemented by conferences, content marketing, and a YouTube/community ecosystem.

Rayyan claims 1 million+ researchers across 20,000+ institutions in 190+ countries and 3 million+ systematic reviews conducted on the platform, supported by compliance certifications including SOC 2 Type 2, ISO 27001, HIPAA, GDPR, CCPA, and WCAG 2.2 AA. The company is privately held, founded in 2016, and operates with 11–50 employees.

Rayyan firmographics

Firmographics
Name
Rayyan
Legal name
Rayyan Systems, Inc.
Website
https://rayyan.ai
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
11–50 employees
Short description
Rayyan is an AI-powered SaaS platform for conducting systematic literature reviews, serving academic researchers, biopharma/HEOR teams, and institutions with screening, deduplication, PICO extraction, and Risk of Bias tools delivered via web, mobile, and API on freemium and tiered subscription plans.
Ownership category
akta.pro rank

Rayyan industry classification

Industry
Product category
Research Management Software
NAICS
Scientific Research and Development Services (5417), Research and Development in the Social Sciences and Humanities (54172)
SIC
Services-Computer Programming, Data Processing, Etc. (7370)
akta.pro industry
PRIMARYBPAHALAN
Healthcare Outcomes & Real-World Evidence (RWE) Analytics
SECONDARYHLACAOAJ
Site & Investigator Platforms (Site Payments, Feasibility, Activation)
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)

Keywords

  • Systematic review software
  • Literature review platform
  • Evidence synthesis tools
  • Research collaboration software
  • AI screening tools

Where Rayyan is headquartered

Location

Headquarters

HQ city
Cambridge
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Rayyan business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Subscription Plans: Tiered subscription model with Free, Essential, Advanced, Business/Academic, and Enterprise tiers. Free plan provides basic access with limited features. Paid plans unlock premium AI features, increased reviewer limits, and team management capabilities. Annual billing offers up to 40% savings compared to quarterly.
  2. Per-Seat Licensing: Paid plans priced per seat (Essential and Advanced tiers for individuals/small teams). Business and Enterprise plans require minimum 5 licenses with custom pricing. Seats can be reassigned as team composition changes.
  3. Institutional Subscriptions: Custom pricing for Business/Academic and Enterprise tiers targeting research departments and institutions. Accepts Purchase Orders and offers bank transfers for institutional subscriptions. Minimum 5 license requirement for Business plan.
  4. API Access: API access provided as a feature in Enterprise tier, enabling integrations with external systems and workflows

Pricing tiers

ModelBillingPrice
FreemiumMonthlyFree forever plan for individual researchers getting started with systematic reviews
SubscriptionQuarterlyEssential AI-powered tools for PhD students and postdocs
SubscriptionQuarterlyAdvanced AI-powered tools for serious professional researchers
SubscriptionAnnualFull platform with ResearchPilot™ AI for research departments and institutions
SubscriptionAnnualUnlimited scale with full governance and dedicated support for large institutions

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

Rayyan product offering

Product offering

Core offering

Rayyan is an AI-powered systematic literature review platform delivered as a tiered SaaS subscription. It enables researchers and institutions to import references, collaborate on screening, deduplicate large reference libraries, extract structured study data, and generate PRISMA-compliant reports. The platform supports the full systematic review workflow from import through reporting, including AI-assisted screening, PICO framework extraction, Risk of Bias assessment, mobile offline screening, and an AI module (ResearchPilot™) for search, screening, and extraction.

Product overview

Rayyan is an AI-powered systematic review and literature review platform offered as a unified SaaS product with tiered subscription plans (Free, Essential, Advanced, Business/Academic, Enterprise). The core platform provides import and organization of references, collaborative screening, deduplication, and PRISMA reporting. The product portfolio includes add-on modules: ResearchPilot™ (AI search, screening, and extraction for institutions with 5 AI modes), Risk Of Bias assessment tool, Workbench for workflow management, Mobile App for iOS/Android, Data Extraction for structured data capture, Systematic Auto Resolver for duplicate removal, PICO Framework for study evaluation, API Access for enterprise integration, and Sampling for randomized subset management. The platform is accessible via web interface, mobile apps, and API, with AI features available across tiers.

Differentiator

Problem solved

Functional benefit

Products and services

  • Rayyan Systematic Review Platform AI-powered systematic literature review SaaS platform that enables import and organization of references, collaborative screening, AI-assisted deduplication, structured data extraction, PICO framework extraction, Risk of Bias assessment, and auto-generated PRISMA flow diagram reporting. Sold via tiered subscriptions (Free, Essential, Advanced, Business/Academic, Enterprise) for individual researchers, research departments, institutions, and biopharma customers.
  • ResearchPilot™ AI module for institutional customers offering five specialized modes: AI Reviewer (automated screening with reasoning notes), AI Analyzer (criteria-based evaluation with justification), Chat with Your Data (Q&A across the dataset), Auto Extraction (structured data extraction from PDFs), and Help Center Mode (contextual in-product support). Available on Business/Academic and Enterprise subscription tiers.
  • Rayyan Mobile App Native mobile application for iOS and Android enabling systematic review screening on the go or offline, with swipe gestures to include/exclude studies, double-tap custom actions, auto-scroll, and offline work capability. Distributed through the Apple App Store (ryn.ai/ios) and Google Play (ryn.ai/android).

Quantifiable outcome

  • Up to 90% time savings on systematic review screening tasks
  • +3 more outcomes

Companies that use Rayyan

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Rayyan technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration9 records

AI capability10 records

Feature9 records

Rayyan partnerships and signals

Strategic signal

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Rayyan competitors and assessment

Company assessment

Direct peers

  • Covidence: Covidence is a widely adopted SaaS platform purpose-built for systematic review screening, data extraction, and PRISMA reporting, serving academic researchers, Cochrane-style evidence syntheses, and guideline developers. It is the most direct competitor to Rayyan's core screening workflow.
  • DistillerSR (Evidence Partners): DistillerSR is an AI-enabled systematic review platform used by regulatory-grade health technology assessment (HTA) teams, government agencies, and pharma HEOR groups. Competes head-to-head with Rayyan in the enterprise / regulated evidence synthesis segment.
  • EPPI-Reviewer: EPPI-Reviewer is an academic systematic review platform developed at UCL for evidence synthesis, including text mining and machine-learning assisted screening. Comparable to Rayyan for academic and Cochrane-adjacent users.
  • JBI SUMARI: JBI SUMARI is the Joanna Briggs Institute's systematic review software for evidence-based healthcare, supporting JBI/Meta-Analysis-style reviews. Directly comparable in workflow to Rayyan for nursing, allied health, and clinical systematic reviews.

Emerging players

  • Elicit: Elicit is an AI research assistant that uses LLMs to search, summarize, and extract data from academic papers. Overlaps with Rayyan's ResearchPilot™ on AI screening and data extraction but competes more broadly with the full literature review workflow.
  • Nested Knowledge: Nested Knowledge is a SaaS platform for systematic literature reviews and evidence mapping with built-in PRISMA reporting and AI-assisted extraction. Direct overlap with Rayyan in pharma/medical device evidence synthesis.
  • Consensus: Consensus is an AI-powered search engine for scientific research that surfaces synthesized answers from peer-reviewed literature. Adjacent competitor to Rayyan for researchers who use it as an alternative starting point to formal systematic reviews.
  • Scite: Scite uses AI to classify how scientific papers cite each other and offers Smart Citations for evidence-based research. Overlaps with Rayyan's screening/extraction value prop for academic and policy researchers.

Broad incumbents

  • Clarivate (Web of Science): Clarivate owns Web of Science, Derwent, and Cortellis, serving academic and life-science research organizations globally. A broad incumbent whose analytics and discovery tools increasingly overlap with Rayyan's workflow, particularly for institutional customers.
  • Elsevier (Embase, Scopus): Elsevier operates Scopus, Embase, ScienceDirect, and tools such as Reaxys that support systematic literature searches and evidence synthesis. A broad incumbent that competes indirectly by integrating discovery and review-adjacent workflows for institutional buyers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Rayyan social profiles

Digital presence

Rayyan compliance and trust

Trust signal

Compliance7 records

Rayyan financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Rayyan leadership team

Management profile

Number of profiles

Profiles2 records

Rayyan funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Rayyan M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rayyan

What does Rayyan do?

Rayyan is an AI-powered systematic literature review platform delivered as a tiered SaaS subscription. It enables researchers and institutions to import references, collaborate on screening, deduplicate large reference libraries, extract structured study data, and generate PRISMA-compliant reports. The platform supports the full systematic review workflow from import through reporting, including AI-assisted screening, PICO framework extraction, Risk of Bias assessment, mobile offline screening, and an AI module (ResearchPilot™) for search, screening, and extraction.

Is Rayyan a public or private company?

Rayyan is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Rayyan founded?

Rayyan was founded in 2016. It employs 11 to 50 people.

Where is Rayyan based?

Rayyan is headquartered in Cambridge, United States, in the North America region.

How does Rayyan make money?

Four revenue lines are on record. Subscription Plans are the primary driver. The others are per-Seat Licensing, institutional Subscriptions and API Access.

Who are Rayyan's main competitors?

Direct peers on record are Covidence, DistillerSR (Evidence Partners), EPPI-Reviewer and JBI SUMARI. Emerging players are Elicit, Nested Knowledge, Consensus and Scite. Broad incumbents are Clarivate (Web of Science) and Elsevier (Embase, Scopus).

Does Rayyan have an API?

Yes. Rayyan offers API Access as a feature available on Enterprise plans. The API allows users to extend Rayyan beyond the interface and integrate with external systems. Available on Enterprise tier with SSO/SAML support. MCP (Model Context Protocol) Server is also available on Enterprise plan. Developer documentation is at www.rayyan.ai/api-access.

What industry is Rayyan in?

Rayyan's product category is Research Management Software. Its primary akta.pro industry code is BPAHALAN, Healthcare Outcomes & Real-World Evidence (RWE) Analytics, with a secondary code of HLACAOAJ, Site & Investigator Platforms (Site Payments, Feasibility, Activation). Its NAICS code is 5417 and its SIC code is 7370.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals